↓ Skip to main content

Drug-related problems and medication reviews among old people with dementia

Overview of attention for article published in BMC Pharmacology and Toxicology, June 2017
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
190 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Drug-related problems and medication reviews among old people with dementia
Published in
BMC Pharmacology and Toxicology, June 2017
DOI 10.1186/s40360-017-0157-2
Pubmed ID
Authors

Bettina Pfister, Jeanette Jonsson, Maria Gustafsson

Abstract

Drug-related problems, including medication errors and adverse drug events, are common among old people. Due to, for example, greater susceptibility to side effects, people with dementia are even more at risk of drug-related problems. The objectives of this study were to assess the occurrence and character of drug-related problems found among old people with dementia or cognitive impairment. Data from a randomized controlled clinical trial exploring the effects of a pharmacist intervention as part of a hospital ward team in patients 65 years and older with dementia or cognitive impairment were used. The study was conducted between 2012 and 2014 in the orthopedic and medicine wards in two hospitals located in Northern Sweden. Drug-related problems identified in this patient group were classified and described, and associations with different factors were investigated. Clinical pharmacists identified at least one DRP in 66% (140/212) of participants in the intervention group, for a total of 310 DRPs. Ineffective drug/inappropriate drug and unnecessary drug therapy were the most common drug-related problems. Discontinuation of drug therapy was the most common action carried out. Drug-related problems were more common among people prescribed a larger number of drugs and among people with an earlier stroke. Drug-related problems are common among people with dementia and cognitive impairment. Comprehensive medication reviews conducted by clinical pharmacists as part of a health care team might be important to prevent, identify and solve these problems.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 190 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 190 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 12%
Student > Bachelor 23 12%
Researcher 16 8%
Student > Ph. D. Student 12 6%
Other 8 4%
Other 37 19%
Unknown 71 37%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 38 20%
Medicine and Dentistry 21 11%
Nursing and Health Professions 15 8%
Biochemistry, Genetics and Molecular Biology 6 3%
Agricultural and Biological Sciences 5 3%
Other 22 12%
Unknown 83 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 June 2017.
All research outputs
#21,264,673
of 23,881,329 outputs
Outputs from BMC Pharmacology and Toxicology
#375
of 450 outputs
Outputs of similar age
#278,317
of 317,607 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#18
of 19 outputs
Altmetric has tracked 23,881,329 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 450 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,607 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.